Functional genomics elucidates regulatory mechanisms of Parkinson’s disease-associated variants

Bibliographic Details
Title: Functional genomics elucidates regulatory mechanisms of Parkinson’s disease-associated variants
Authors: Rui Chen, Jiewei Liu, Shiwu Li, Xiaoyan Li, Yongxia Huo, Yong-Gang Yao, Xiao Xiao, Ming Li, Xiong-Jian Luo
Source: BMC Medicine, Vol 20, Iss 1, Pp 1-18 (2022)
Publisher Information: BMC, 2022.
Publication Year: 2022
Collection: LCC:Medicine
Subject Terms: Parkinson’s disease (PD), Genome-wide association studies (GWASs), Single-nucleotide polymorphisms (SNPs), Functional genomics, Transcription factor (TF) binding, Regulatory mechanisms, Medicine
More Details: Abstract Background Genome-wide association studies (GWASs) have identified multiple risk loci for Parkinson’s disease (PD). However, identifying the functional (or potential causal) variants in the reported risk loci and elucidating their roles in PD pathogenesis remain major challenges. To identify the potential causal (or functional) variants in the reported PD risk loci and to elucidate their regulatory mechanisms, we report a functional genomics study of PD. Methods We first integrated chromatin immunoprecipitation sequencing (ChIP-Seq) (from neuronal cells and human brain tissues) data and GWAS-identified single-nucleotide polymorphisms (SNPs) in PD risk loci. We then conducted a series of experiments and analyses to validate the regulatory effects of these (i.e., functional) SNPs, including reporter gene assays, allele-specific expression (ASE), transcription factor (TF) knockdown, CRISPR-Cas9-mediated genome editing, and expression quantitative trait loci (eQTL) analysis. Results We identified 44 SNPs (from 11 risk loci) affecting the binding of 12 TFs and we validated the regulatory effects of 15 TF binding-disrupting SNPs. In addition, we also identified the potential target genes regulated by these TF binding-disrupting SNPs through eQTL analysis. Finally, we showed that 4 eQTL genes of these TF binding-disrupting SNPs were dysregulated in PD cases compared with controls. Conclusion Our study systematically reveals the gene regulatory mechanisms of PD risk variants (including widespread disruption of CTCF binding), generates the landscape of potential PD causal variants, and pinpoints promising candidate genes for further functional characterization and drug development.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1741-7015
Relation: https://doaj.org/toc/1741-7015
DOI: 10.1186/s12916-022-02264-w
Access URL: https://doaj.org/article/903a6fb3fbbe4cf59705ec86a9b109a1
Accession Number: edsdoj.903a6fb3fbbe4cf59705ec86a9b109a1
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:17417015
DOI:10.1186/s12916-022-02264-w
Published in:BMC Medicine
Language:English